telmisartan has been researched along with HIV Coinfection in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foster, T; García-Fiñana, M; Jaki, T; Kemp, GJ; Khoo, S; Kolamunnage-Dona, R; Pirmohamed, M; Pushpakom, S; Spowart, C; Taylor, C; Williamson, P | 1 |
| Bastow, B; Currier, JS; Deleage, C; Douek, DC; Estes, JD; Fichtenbaum, CJ; Kitch, DW; Klingman, KL; Lake, JE; Lederman, MM; Luque, AE; Magyar, C; McComsey, GA; Nelson, SD; Utay, NS; Yeh, E | 1 |
| Currier, JS; Lake, JE; Tseng, CH | 1 |
| Bowden, J; Jennison, C; Stallard, N; Wason, J | 1 |
| Currier, JS; Hodis, HN; Kelesidis, T; Lake, JE; Liao, DH; Seang, S; Stein, JH | 1 |
| García-Fiñana, M; Jaki, T; Kemp, GJ; Khoo, S; Kolamunnage-Dona, R; Pirmohamed, M; Pushpakom, SP; Spowart, C; Taylor, C; Vora, J; Whitehead, J; Williamson, P | 1 |
| Hulgan, T; Lake, JE; Le, CN; Milne, GL; Tseng, CH | 1 |
| Falasca, K; Mancino, P; Pizzigallo, E; Ucciferri, C; Vecchiet, J | 1 |
| Di Iorio, A; Falasca, K; Mancino, P; Ucciferri, C; Vecchiet, J | 1 |
| Jaki, T; Wason, JM | 1 |
5 trial(s) available for telmisartan and HIV Coinfection
| Article | Year |
|---|---|
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral
Topics: Benzimidazoles; Benzoates; HIV; HIV Infections; Humans; Insulin Resistance; Telmisartan | 2020 |
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone.
Topics: Adipose Tissue; Adult; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Female; Fibrosis; HIV Infections; Humans; Inflammation; Lymph Nodes; Male; Middle Aged; PPAR gamma; Telmisartan | 2018 |
A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial.
Topics: Adiposity; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antiretroviral Therapy, Highly Active; Benzimidazoles; Benzoates; Female; Glucose; HIV Infections; Humans; Inflammation Mediators; Intra-Abdominal Fat; Lipid Metabolism; Male; Middle Aged; Organ Size; Pilot Projects; Sex Factors; Telmisartan | 2013 |
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Benzimidazoles; Benzoates; Clinical Protocols; Drug Therapy, Combination; Female; HIV Infections; Humans; Insulin Resistance; Male; Middle Aged; Research Design; Telmisartan; Young Adult | 2015 |
Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.
Topics: Adipose Tissue; Adult; Angiotensin II Type 1 Receptor Blockers; Anthropometry; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzimidazoles; Benzoates; Body Fat Distribution; Eicosanoids; Female; HIV Infections; Humans; Inflammation; Lipodystrophy; Male; Middle Aged; Oxidative Stress; Pilot Projects; Prospective Studies; Sex Factors; Telmisartan; Waist-Hip Ratio | 2017 |
5 other study(ies) available for telmisartan and HIV Coinfection
| Article | Year |
|---|---|
A multi-stage drop-the-losers design for multi-arm clinical trials.
Topics: Benzimidazoles; Benzoates; Controlled Clinical Trials as Topic; HIV Infections; Humans; Insulin Resistance; Patient Selection; Research Design; Sample Size; Telmisartan; Treatment Outcome | 2017 |
Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study.
Topics: Angiotensin II Type 1 Receptor Blockers; Anti-HIV Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Female; HIV Infections; Humans; Male; Middle Aged; Pilot Projects; Risk Factors; Telmisartan | 2015 |
Proteinuria in an African HIV-infected patient: effects of telmisartan.
Topics: Africa; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; HIV Infections; Humans; Male; Middle Aged; Proteinuria; Telmisartan | 2011 |
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Endothelium, Vascular; Glomerular Filtration Rate; HIV Infections; Humans; Hypertension; Insulin Resistance; Italy; Kidney; Male; Middle Aged; Telmisartan; Time Factors; Treatment Outcome | 2012 |
Optimal design of multi-arm multi-stage trials.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Retroviral Agents; Benzimidazoles; Benzoates; Bias; Clinical Trials as Topic; Computer Simulation; Drug Therapy, Combination; Endpoint Determination; HIV Infections; Humans; Insulin Resistance; Research Design; Sample Size; Telmisartan | 2012 |